Many esophageal diseases need esophageal replacement. Replacement with autograft leads to great damage and complications. The existing artificial esophagus, however, cannot match the demands of esophageal replacement. The study of tissue-engineered esophagus is the hope to solve these problems. This article reviews the progression of tissue-engineered esophagus.

With its excellent character , Holmium:Yag laser had been used in more and more areas of medicine. It's growing success is a result of its excellent performance as both a lithotriptor and a surgical laser on soft tissues. The low level laser power is a good stimulator to the growth of biological tissue and the metabolism of cells.

Active tumor targeting drug delivery system( ATTDDS) can selectively combine with and react to the target tissue at the cellular or sub-cellular level, making it possible for drugs to be distributed in a controlled manner and released in a slow and continuous manner, subsequently resulting in enhanced anti-cancer drugs effects and reduced adverse effects on normal tissues. Although there are many problems need to be solved in research on ATTDDS, and there is still a long way to go before it can be used clinically, its roles in overcoming adverse effects of cancer treatment and improving the therapeutic effect are valuable. Generally, ATTDDS is an ideal anti-tumor drug dosage and has a promising prospect. This paper introduces the effects and characteristics of various types of ATTDDS as well as their problems and countermeasures, hoping to provide research ideas and methods for the anti-tumor targeted drug delivery.

To establish a rapid and accurate method for the determination of 34 chemical hypotensors which were illegally added into the blood pressure lowering class Chinese patent medicines (CPM) and the blood pressure regulating class health foods. The UPLC-MS/MS method was adopted. The samples were extracted with methanol by ultrasonic processing and separated on a Waters Acquity BEH-C18 (100 mm × 2.1 mm, 1.7 μm) column with 0.1% formic acid methanol (A) and 0.1% formic acid water solution (B) as the mobile phase by gradient elution (0-5 min, 32% A; 5-8 min, 32%-50% A; 8-12 min, 50% A; 12-14 min, 50%-60% A; 14-16 min, 60%-80% A; 16-18 min, 80% A; 18-19 min, 80%-90% A; 19-20 min, 90%-100% A; 20-21 min, 100% A; and 21-22 min, 100%-32% A) at a flow rate of 0.2 mL/min, and the column temperature was 40℃. A positive-ion (ESI⁺) source and a MRM mode were used to separate and quantitatively determine the chemical hypotensors. The obtained molecular ions, fragment ions, and retention time for MRM channels were used to identify the 34 kinds of drugs by comparison with those of reference substances. The obtained peak areas were used to determine the accurate content of chemical hypotensors in the blood pressure lowering class CPM and the blood pressure regulating class health foods. A good resolution of 34 kinds of chemical drugs, including clonidine, captopril, yohimban-16-carboxylicacid, L-tyrosine, hydrochlorothiazide, furosemide, indapamide, minoxidil, hydralazine, atenolol, lisinopril, dibazole, metoprolol, bisoprolol, prazosin, terazosin, propranolol, enalapril, quinapril, benazepril, dilthiazem, doxazosin, nicardipine, nifedipine, amlodipine, nimodipine, felodipine, nitrendipine nisoldipine, valsartan, telmisartan, candesartan cilexetil, rbesartan, and olmesartan medoxomil was obtained under this UPLC and MS/MS condition. The limits of qualitative and quantitative were in the range of 0.1-0.5 and 0.3-1.5 ng/g. The standard addition recoveries were in the range of 81.4%-118.9%. The method is simple, accurate, and with high sensitivity, which can be used for the determination of illegally added chemical hypotensors in CPM and health foods.

OBJECTIVE: Chemotherapy is the primary treatment in addition to surgery and radiotherapy in cancer therapy, and drug resistance of tumor cells remains a major obstacle to successful cancer chemotherapy. In present study, we aim to develop a novel drug delivery system, ie, doxorubicin (DOX) conjugated poly (amido amine) (PAMAM) dendrimers was further decorated by hyaluronic acid (HA) (DOX-PAMAM-HA) to circumvent drug resistance in cancer cells. METHODS: Nuclear magnetic resonance (NMR) was performed to confirm the synthesis of the DOX-PAMAM-HA, its average size was analyzed by a dynamic light-scattering detector, and its morphological examination was performed by transmission electron microscope (TEM). To study the ability of DOXPAMAM-HA in overcome multi-drug resistance, the multi-drug resistant breast cancer cells (MCF-7/ADR cells) was used as model cell, and the confocal microscopy was utilized to observe the drug intracellular distribution, moreover, the hematoxylin-eosin staining (HE) studies were employed to evaluate the tissue staining and toxicity. RESULTS: The drug delivery system DOX-PAMAM-HA was successfully synthesized, which is spherical particles with a average particle size of 323 nm. The uptake in MCF-7/ADR cells for DOXPAMAM-HA is higher than that of DOX solution, and DOX-PAMAM-HA maybe distribute mainly in the lysosome of the cells, which could increase the accumulation of DOX in its action target (nucleus). In contrast, DOX solution was mainly diffused in the cytoplasm of the tumor cells. Furthermore, less toxicity in heart and spleen induced by DOX-PAMAM-HA in comparing to that of DOX solution after intravenous administration for 3 weeks. CONCLUSION: DOX-PAMAM-HA is a prospect future nanodrug delivery system in overcoming drug-resistance of tumor cells.

Objective To analyze the clinical diagnosis and therapeutic effect of primary middle lobe lung cancer,in order to provide evidence for clinical diagnosis and treatment.Methods The clinical data of 45 cases of primary middle lobe lung cancer treated by surgery from January 2002 to January 2007 were ana- lyzed retrospectively.The operation style includes:simple middle lobectomy 12 cases(26.7 %),middle or up- per lobectomy 10 cases(22.2 %),right lung total resection 5 cases(11.1%).Chest exploration was done on 2 cases(4.44 %),palliative resection or vedged resection 2 cases(4.44 %).Results 1 case died from lung in- fection and respiratory failure(2.22 %).15 cases with arrhythmia (33.3 %), 1 case with chylothorax were cured after conservative treatment.The survival rate of 1,3,5 year were 82.1%,64.3 %,32.1% respectively. Conclusion The treatment of primary middle lobe lung cancer is dominated by regular lobectomy. It is difficult to perform middle lobectomy,so double or total lobectomy is done generally.Owing to the more postoperative complications, it should be cautious to perform sleeve resection.It should be avoided to do vedged resection for primary middle lobe lung cancer in order to lessen local recurrence.

Carcinoma, Hepatocellular ; therapy ; Catheter Ablation ; Chemoembolization, Therapeutic ; Combined Modality Therapy ; Humans ; Liver Neoplasms ; therapy ; Liver Transplantation

Adolescent ; Child ; Child, Preschool ; Critical Care ; Fatty Acid-Binding Proteins ; blood ; metabolism ; urine ; Female ; Gastrointestinal Diseases ; blood ; urine ; Humans ; Male ; Metabolic Diseases ; blood ; urine

Diagnosis, Differential ; Humans ; Lymphoproliferative Disorders ; diagnosis ; Stomach ; Stomach Neoplasms ; diagnosis

Objective To explore risk factors for adult leukemia. Methods 192 patients with leukemia and 241 community controls were chosen to carry out a case-control study for finding the indoor environmental factors and the other risk factors for leukemia. The data was statistically analyzed by unconditional logistic regression. Results It was demonstrated as the risk factors for leukemia that the occupation (OR=7.06, P